Cartesian Therapeutics, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $89.9M | $145.7M | $113.4M |
| Jun 2022 | $98.5M | $188.1M | $138.1M |
| Sep 2022 | $93.4M | $178.3M | $112.8M |
| Dec 2022 | $72.1M | $165.9M | $106.4M |
| Mar 2023 | $81.1M | $155.7M | $125.9M |
| Jun 2023 | $74.1M | $139.5M | $112.0M |
| Sep 2023 | $45.7M | $106.0M | $79.6M |
| Dec 2023 | $444.7M | $305.1M | $76.9M |
| Mar 2024 | $442.0M | $325.2M | $103.4M |
| Jun 2024 | $449.2M | $347.7M | $87.2M |
| Sep 2024 | $454.6M | $455.3M | $219.2M |
| Dec 2024 | $441.8M | $435.0M | $212.6M |
| Mar 2025 | $430.9M | $409.1M | $180.4M |
| Jun 2025 | $391.4M | $388.9M | $160.3M |
| Sep 2025 | $408.5M | $372.7M | $143.4M |
| Dec 2025 | $422.7M | $296.4M | $125.1M |
| Mar 2026 | $436.5M | $288.4M | $118.6M |
| Jun 2026 | $443.9M | $318.6M | $147.6M |